H
Animals
Antibodies, Monoclonal, Humanized
/ pharmacology
Cell Line, Tumor
Cell Proliferation
/ drug effects
Gene Expression Regulation, Neoplastic
/ drug effects
Humans
Immunoglobulin G
/ immunology
Mice
Pancreatic Neoplasms
/ drug therapy
Receptor, ErbB-2
/ antagonists & inhibitors
Xenograft Model Antitumor Assays
HER2
antitumor activity
monoclonal antibody
Journal
Monoclonal antibodies in immunodiagnosis and immunotherapy
ISSN: 2167-9436
Titre abrégé: Monoclon Antib Immunodiagn Immunother
Pays: United States
ID NLM: 101590955
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
20
5
2020
medline:
23
4
2021
entrez:
20
5
2020
Statut:
ppublish
Résumé
Overexpression of human epidermal growth factor receptor 2 (HER2) has been reported in breast cancer, gastric, lung, colorectal, oral, and pancreatic cancers. HER2 expression is associated with poor clinical outcomes. An anti-HER2 humanized antibody, trastuzumab, has improved survival rates in patients with HER2-overexpressing breast and gastric cancers. Previously, we established a novel anti-HER2 monoclonal antibody (mAb), H
Identifiants
pubmed: 32423281
doi: 10.1089/mab.2020.0011
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Immunoglobulin G
0
ERBB2 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM